Copyright Reports & Markets. All rights reserved.

Global Colorectal Cancer Screening Test Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Colorectal Cancer Screening Test by Type
    • 1.3.1 Overview: Global Colorectal Cancer Screening Test Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Colorectal Cancer Screening Test Consumption Value Market Share by Type in 2025
    • 1.3.3 Fecal Immunochemical Test (FIT)
    • 1.3.4 Fecal Occult Blood Test (FOBT)
    • 1.3.5 Stool-DNA Test
    • 1.3.6 Other
  • 1.4 Global Colorectal Cancer Screening Test Market by Application
    • 1.4.1 Overview: Global Colorectal Cancer Screening Test Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals & Clinics
    • 1.4.3 Clinical Laboratories
    • 1.4.4 Diagnostic Imaging Centres
    • 1.4.5 Others
  • 1.5 Global Colorectal Cancer Screening Test Market Size & Forecast
  • 1.6 Global Colorectal Cancer Screening Test Market Size and Forecast by Region
    • 1.6.1 Global Colorectal Cancer Screening Test Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Colorectal Cancer Screening Test Market Size by Region, (2021-2032)
    • 1.6.3 North America Colorectal Cancer Screening Test Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Colorectal Cancer Screening Test Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Colorectal Cancer Screening Test Market Size and Prospect (2021-2032)
    • 1.6.6 South America Colorectal Cancer Screening Test Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Colorectal Cancer Screening Test Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Novigenix SA
    • 2.1.1 Novigenix SA Details
    • 2.1.2 Novigenix SA Major Business
    • 2.1.3 Novigenix SA Colorectal Cancer Screening Test Product and Solutions
    • 2.1.4 Novigenix SA Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Novigenix SA Recent Developments and Future Plans
  • 2.2 Eiken Chemical Co., Ltd.
    • 2.2.1 Eiken Chemical Co., Ltd. Details
    • 2.2.2 Eiken Chemical Co., Ltd. Major Business
    • 2.2.3 Eiken Chemical Co., Ltd. Colorectal Cancer Screening Test Product and Solutions
    • 2.2.4 Eiken Chemical Co., Ltd. Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Eiken Chemical Co., Ltd. Recent Developments and Future Plans
  • 2.3 Clinical Genomics Pathology, Inc.
    • 2.3.1 Clinical Genomics Pathology, Inc. Details
    • 2.3.2 Clinical Genomics Pathology, Inc. Major Business
    • 2.3.3 Clinical Genomics Pathology, Inc. Colorectal Cancer Screening Test Product and Solutions
    • 2.3.4 Clinical Genomics Pathology, Inc. Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Clinical Genomics Pathology, Inc. Recent Developments and Future Plans
  • 2.4 Exact Sciences Corporation
    • 2.4.1 Exact Sciences Corporation Details
    • 2.4.2 Exact Sciences Corporation Major Business
    • 2.4.3 Exact Sciences Corporation Colorectal Cancer Screening Test Product and Solutions
    • 2.4.4 Exact Sciences Corporation Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Exact Sciences Corporation Recent Developments and Future Plans
  • 2.5 Epigenomics AG
    • 2.5.1 Epigenomics AG Details
    • 2.5.2 Epigenomics AG Major Business
    • 2.5.3 Epigenomics AG Colorectal Cancer Screening Test Product and Solutions
    • 2.5.4 Epigenomics AG Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Epigenomics AG Recent Developments and Future Plans
  • 2.6 BioMerieux S.A.
    • 2.6.1 BioMerieux S.A. Details
    • 2.6.2 BioMerieux S.A. Major Business
    • 2.6.3 BioMerieux S.A. Colorectal Cancer Screening Test Product and Solutions
    • 2.6.4 BioMerieux S.A. Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BioMerieux S.A. Recent Developments and Future Plans
  • 2.7 Olympus Corporation
    • 2.7.1 Olympus Corporation Details
    • 2.7.2 Olympus Corporation Major Business
    • 2.7.3 Olympus Corporation Colorectal Cancer Screening Test Product and Solutions
    • 2.7.4 Olympus Corporation Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Olympus Corporation Recent Developments and Future Plans
  • 2.8 Sysmex Corporation
    • 2.8.1 Sysmex Corporation Details
    • 2.8.2 Sysmex Corporation Major Business
    • 2.8.3 Sysmex Corporation Colorectal Cancer Screening Test Product and Solutions
    • 2.8.4 Sysmex Corporation Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sysmex Corporation Recent Developments and Future Plans
  • 2.9 Fujifilm Holdings Corporation
    • 2.9.1 Fujifilm Holdings Corporation Details
    • 2.9.2 Fujifilm Holdings Corporation Major Business
    • 2.9.3 Fujifilm Holdings Corporation Colorectal Cancer Screening Test Product and Solutions
    • 2.9.4 Fujifilm Holdings Corporation Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Fujifilm Holdings Corporation Recent Developments and Future Plans
  • 2.10 Siemens Healthineers AG (Siemens AG)
    • 2.10.1 Siemens Healthineers AG (Siemens AG) Details
    • 2.10.2 Siemens Healthineers AG (Siemens AG) Major Business
    • 2.10.3 Siemens Healthineers AG (Siemens AG) Colorectal Cancer Screening Test Product and Solutions
    • 2.10.4 Siemens Healthineers AG (Siemens AG) Colorectal Cancer Screening Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Siemens Healthineers AG (Siemens AG) Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Colorectal Cancer Screening Test Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Colorectal Cancer Screening Test by Company Revenue
    • 3.2.2 Top 3 Colorectal Cancer Screening Test Players Market Share in 2025
    • 3.2.3 Top 6 Colorectal Cancer Screening Test Players Market Share in 2025
  • 3.3 Colorectal Cancer Screening Test Market: Overall Company Footprint Analysis
    • 3.3.1 Colorectal Cancer Screening Test Market: Region Footprint
    • 3.3.2 Colorectal Cancer Screening Test Market: Company Product Type Footprint
    • 3.3.3 Colorectal Cancer Screening Test Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Colorectal Cancer Screening Test Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Colorectal Cancer Screening Test Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Colorectal Cancer Screening Test Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Colorectal Cancer Screening Test Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Colorectal Cancer Screening Test Consumption Value by Type (2021-2032)
  • 6.2 North America Colorectal Cancer Screening Test Market Size by Application (2021-2032)
  • 6.3 North America Colorectal Cancer Screening Test Market Size by Country
    • 6.3.1 North America Colorectal Cancer Screening Test Consumption Value by Country (2021-2032)
    • 6.3.2 United States Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Colorectal Cancer Screening Test Consumption Value by Type (2021-2032)
  • 7.2 Europe Colorectal Cancer Screening Test Consumption Value by Application (2021-2032)
  • 7.3 Europe Colorectal Cancer Screening Test Market Size by Country
    • 7.3.1 Europe Colorectal Cancer Screening Test Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 7.3.3 France Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Colorectal Cancer Screening Test Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Colorectal Cancer Screening Test Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Colorectal Cancer Screening Test Market Size by Region
    • 8.3.1 Asia-Pacific Colorectal Cancer Screening Test Consumption Value by Region (2021-2032)
    • 8.3.2 China Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 8.3.5 India Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Colorectal Cancer Screening Test Consumption Value by Type (2021-2032)
  • 9.2 South America Colorectal Cancer Screening Test Consumption Value by Application (2021-2032)
  • 9.3 South America Colorectal Cancer Screening Test Market Size by Country
    • 9.3.1 South America Colorectal Cancer Screening Test Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Colorectal Cancer Screening Test Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Colorectal Cancer Screening Test Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Colorectal Cancer Screening Test Market Size by Country
    • 10.3.1 Middle East & Africa Colorectal Cancer Screening Test Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Colorectal Cancer Screening Test Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Colorectal Cancer Screening Test Market Drivers
  • 11.2 Colorectal Cancer Screening Test Market Restraints
  • 11.3 Colorectal Cancer Screening Test Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Colorectal Cancer Screening Test Industry Chain
  • 12.2 Colorectal Cancer Screening Test Upstream Analysis
  • 12.3 Colorectal Cancer Screening Test Midstream Analysis
  • 12.4 Colorectal Cancer Screening Test Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Colorectal Cancer Screening Test market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    A colorectal cancer screening test refers to a diagnostic procedure aimed at detecting early signs of colorectal cancer or precancerous conditions in individuals without symptoms. These screening tests include various methods such as stool-based tests, imaging tests like colonoscopy, sigmoidoscopy, and virtual colonoscopy, as well as blood tests for tumor markers. The primary goal of colorectal cancer screening is to identify abnormalities in the colon or rectum at an early stage when cancer is most treatable, allowing for timely intervention and improved patient outcomes.
    The market for colorectal cancer screening tests is witnessing significant growth due to increasing awareness about the importance of early detection and the rising prevalence of colorectal cancer worldwide. Governments, healthcare organizations, and advocacy groups are actively promoting colorectal cancer screening programs to reduce mortality rates and healthcare costs associated with late-stage diagnoses. Stool-based tests, such as fecal occult blood tests (FOBT) and fecal immunochemical tests (FIT), are gaining popularity due to their non-invasive nature and convenience for patients. Additionally, advancements in imaging technologies and blood-based biomarkers are improving the accuracy and efficacy of colorectal cancer screening tests. However, challenges such as patient compliance, access to screening facilities, and reimbursement issues hinder market growth. Nonetheless, with ongoing research and development efforts aimed at enhancing test accuracy, expanding screening programs, and improving patient awareness, the colorectal cancer screening test market is expected to continue growing, particularly in regions with aging populations and increasing healthcare infrastructure.
    This report is a detailed and comprehensive analysis for global Colorectal Cancer Screening Test market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Colorectal Cancer Screening Test market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Colorectal Cancer Screening Test market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Colorectal Cancer Screening Test market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Colorectal Cancer Screening Test market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Colorectal Cancer Screening Test
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Colorectal Cancer Screening Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novigenix SA, Eiken Chemical Co., Ltd., Clinical Genomics Pathology, Inc., Exact Sciences Corporation, Epigenomics AG, BioMerieux S.A., Olympus Corporation, Sysmex Corporation, Fujifilm Holdings Corporation, Siemens Healthineers AG (Siemens AG), etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Colorectal Cancer Screening Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Fecal Immunochemical Test (FIT)
    Fecal Occult Blood Test (FOBT)
    Stool-DNA Test
    Other
    Market segment by Application
    Hospitals & Clinics
    Clinical Laboratories
    Diagnostic Imaging Centres
    Others
    Market segment by players, this report covers
    Novigenix SA
    Eiken Chemical Co., Ltd.
    Clinical Genomics Pathology, Inc.
    Exact Sciences Corporation
    Epigenomics AG
    BioMerieux S.A.
    Olympus Corporation
    Sysmex Corporation
    Fujifilm Holdings Corporation
    Siemens Healthineers AG (Siemens AG)
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Colorectal Cancer Screening Test product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Colorectal Cancer Screening Test, with revenue, gross margin, and global market share of Colorectal Cancer Screening Test from 2021 to 2026.
    Chapter 3, the Colorectal Cancer Screening Test competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Colorectal Cancer Screening Test market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Screening Test.
    Chapter 13, to describe Colorectal Cancer Screening Test research findings and conclusion.

    Buy now